Evidence map›Paper›PMID 40120998›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2025

Lung rehabilitation using xenogeneic cross-circulation does not lead to hyperacute rejection in a human lung transplantation model.

Kaitlyn M Tracy, Timothy R Harris, Mark Petrovic, Michael Cortelli, William Tucker, Sean François, Yutaka Shishido, Victoria Simon, Brandon Petree, Carl A Johnson and 18 more

Abstract read
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Kaitlyn M TracyDivision of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Timothy R HarrisDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Mark PetrovicDepartment Biomedical Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.
Michael CortelliDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
William TuckerDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Sean FrançoisDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Yutaka ShishidoDivision of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Victoria SimonDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Brandon PetreeDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Carl A JohnsonDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Wei K WuDivision of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Nancy L CardwellDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Elizabeth SimondsDepartment Biomedical Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee.
TiOluwanimi T AdesanyaDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Avery K FortierSchool of Arts and Sciences, Vanderbilt University, Nashville, Tennessee.
Kimya RaietparvarSchool of Arts and Sciences, Vanderbilt University, Nashville, Tennessee.
Stuart R LandstreetSchool of Arts and Sciences, Vanderbilt University, Nashville, Tennessee.
Nancy WickershamSchool of Arts and Sciences, Vanderbilt University, Nashville, Tennessee.
John D O'NeillCSO, Xylyx, Inc. New York, New York.
John PolandDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Ashish S ShahDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Stephen DeVriesDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Christian CrannellDivision of Kidney and Pancreas Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Charles C MarboeDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, New York.
Rei UkitaDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Caitlin T DemarestDepartment of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Ciara M ShaverDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: ciara.shaver@vumc.org.
Matthew BacchettaDepartment of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. Electronic address: matthew.bacchetta@vumc.org.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Surgical Oncology Training GrantT32CA106183 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI James Richard Goldenring · 2004 to 2026
$6.0M
Immunogenomic analysis of donor lung injury and its impact on clinical outcomes after lung transplantationR01HL160551 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ciara M Shaver · 2022 to 2026
$3.4M
Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantationR44HL182545 · NHLBI · XYLYX BIO, INC. · PI Matthew Dominic Bacchetta, John David O'Neill · 2025 to 2026
$3.0M
The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary HypertensionR01HL171577 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Matthew Dominic Bacchetta · 2024 to 2026
$2.2M
Multidisciplinary Research Training in Pediatric Pulmonary Vascular DiseaseT32HL160508 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Steven Herbert Abman, Eric Douglas Austin · 2022 to 2026
$1.7M
Acquisition of a super-resolution optical microscopeS10OD012324 · OD · VANDERBILT UNIVERSITY · PI TYSKA, MATTHEW J · 2012 to 2012
$1.1M
NCI NIH HHS P30 CA068485NCI NIH HHS T32 CA106183NEI NIH HHS P30 EY008126NHLBI NIH HHS R01 HL160551NHLBI NIH HHS R01 HL171577NHLBI NIH HHS R44 HL182545NHLBI NIH HHS T32 HL160508NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIGMS NIH HHS T32 GM007347NIH HHS S10 OD012324NIH HHS S10 OD023475NIH HHS S10 OD034315
6 · The paper itself

Abstract

backgroundAccess to life-saving lung transplantation remains limited by a shortage of donor organs. We have previously described rehabilitation of discarded human donor lungs to a quality suitable for transplantation using cross-circulation of whole blood between xeno-support swine and human lungs. However, the immunologic implications of transplanting rehabilitated lungs remain unknown.

methodsHuman donor lungs declined for clinical transplantation (N = 5) and underwent xenogeneic cross-circulation (XC) for up to 12 hours. To model subsequent human transplantation, lungs were re-exposed to autologous human whole blood via normothermic ex vivo machine perfusion for up to 6 hours. Upon human blood re-exposure (HBR), lungs were evaluated for evidence of hyperacute rejection (HAR) through physiologic assessments and tissue analyses including histology, immunostaining, and flow cytometry.

resultsUpon HBR, lungs showed no significant change in physiologic function relative to the end of cross-circulation (PaO

conclusionsOur findings indicate that transient exposure of human donor lungs to XC does not result in HAR upon simulated human transplantation, representing an important step toward clinical translation of this donor organ rehabilitation platform.

Indexed as

Graft RejectionLungLung TransplantationAnimalsFemaleHumansMaleSwineTissue DonorsTransplantation, Heterologoushuman lung transplantation modellung rehabilitationlung transplantationtransplant immunologyxenogeneic cross-circulation

Identifiers

PMID40120998
PMCPMC12191440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.